• Lypressin Acetate: Molecular Pharmacology and Translational

  2026-07-09

  Explore the molecular pharmacology of Lypressin acetate, a vasopressin analog, and its translational potential in both antidiuretic and emerging antiviral research. This article delivers a deeper mechanistic perspective and critical protocol insights for advanced applications.

• SU 5402: Advancing Translational Insights in Cancer and Beyo

  2026-07-09

  This article explores the mechanistic impact and strategic use of SU 5402, a potent receptor tyrosine kinase inhibitor, in translational research. Blending detailed biological rationale, experimental validation, and forward-looking guidance, it addresses how SU 5402 empowers breakthrough studies in cancer biology—especially multiple myeloma—and positions itself at the interface of emerging stem cell and neuronal disease models.

• (S)-(+)-Dimethindene maleate: M2 Antagonist for Research Wor

  2026-07-08

  (S)-(+)-Dimethindene maleate provides selective antagonism at the muscarinic M2 and histamine H1 receptors, enabling precise modulation in autonomic regulation, cardiovascular, and respiratory system research. It is best applied where receptor selectivity and solution stability are critical but is not suitable for diagnostic or clinical applications or long-term solution storage.

• ASB3 E3 Ligase Targets MAVS to Downregulate Antiviral Immuni

  2026-07-08

  This study reveals that the E3 ubiquitin ligase ASB3 suppresses antiviral innate immunity by promoting K48-linked polyubiquitination and proteasomal degradation of the MAVS adaptor protein. The findings uncover a previously unrecognized regulatory mechanism of interferon signaling, with implications for understanding host-pathogen interactions and viral immune evasion.

• Mutational Drivers and Drug Resistance in Myeloma Cell Lines

  2026-07-07

  This article reviews a comprehensive exome sequencing study of 30 human multiple myeloma cell lines, revealing key genetic mutations and pathways that contribute to tumor progression and drug resistance. The findings provide a robust framework for selecting relevant models and designing targeted interventions in hematological malignancy research.

• Moesin as a Biomarker of Endothelial Injury in Sepsis: Insig

  2026-07-07

  The reference study identifies moesin (MSN) as a novel biomarker indicative of endothelial injury severity in sepsis, linking its serum levels to inflammatory and permeability changes. This finding advances our understanding of sepsis pathogenesis and offers a foundation for translational research into endothelial dysfunction.

• Moesin as a Biomarker of Endothelial Injury in Sepsis Models

  2026-07-06

  Chen et al. (2021) demonstrate that moesin (MSN) is a promising biomarker for endothelial injury severity in sepsis. Their findings link MSN expression to both clinical severity and mechanistic pathways, providing new avenues for evaluating vascular dysfunction and supporting translational research in sepsis.

• Applied Use of Anti-ROR1 Antibody (Zilovertamab) in Translat

  2026-07-06

  Leverage Anti-ROR1 Antibody (Zilovertamab) for precision inhibition of Wnt5a-induced ROR1 signaling in cancer and liver injury models. This article delivers actionable protocols, troubleshooting strategies, and cross-domain insights that distinguish APExBIO's antibody in advanced research workflows.

• AP20187: Chemical Inducer of Dimerization for Precision Rese

  2026-07-05

  AP20187 empowers researchers with tunable, high-fidelity control over protein-protein interactions and signaling in conditional gene therapy and metabolic studies. Its robust solubility, validated in vivo efficacy, and unique ability to regulate fusion protein dimerization enable advanced experimental designs and streamlined troubleshooting.

• BATF2-ATF3 Axis Drives Mitochondrial Dysfunction in IVDD Pro

  2026-07-04

  A recent study delineates how the BATF2-ATF3 transcriptional axis exacerbates intervertebral disc degeneration (IVDD) by destabilizing mitochondrial homeostasis in nucleus pulposus cells. This molecular insight suggests that targeting BATF2 or ATF3 could represent a novel strategy for IVDD intervention.

• Gamma-linolenic Acid (GLA): Precision Modulator in Inflammat

  2026-07-03

  Explore the advanced role of Gamma-linolenic acid (GLA) as a precision modulator in anti-inflammatory and immune signaling research. This in-depth analysis reveals unique mechanistic insights, practical assay guidance, and new perspectives on its translational potential.

• Intravitreal Metformin Reduces CNV and Retinal Degeneration

  2026-07-03

  Xiao et al. present evidence that intravitreal metformin suppresses choroidal neovascularization and protects against light-induced retinal degeneration in mouse models. The study demonstrates both anti-angiogenic and neuroprotective effects, suggesting metformin's potential as an accessible intervention for neovascular age-related macular degeneration (nAMD).

• BCECF-AM for Live-Cell pH Imaging: Mechanistic Insights and

  2026-07-02

  Explore how BCECF-AM, a leading intracellular pH indicator, advances our understanding of plant autophagy and vacuolar acidification. This article reveals mechanistic details and practical protocols, offering fresh perspectives beyond standard assay guides.

• FITC-Concanavalin A (ConA) Conjugate: Technical Lab Guidance

  2026-07-02

  FITC-Concanavalin A (ConA) Conjugate provides researchers with a direct, fluorescence-based tool for detecting α-D-glucose and α-D-mannose residues on cell surfaces using immunofluorescence or flow cytometry. It is intended for applications in carbohydrate detection within defined storage and application parameters, and is not suitable for non-glycan targets or protocols requiring extended reagent stability.

• PLK1 Regulation of p31comet in Mitotic Checkpoint Disassembl

  2026-07-01

  This study defines the mechanistic role of PLK1 in phosphorylating p31comet, thereby suppressing its function in mitotic checkpoint complex (MCC) disassembly. The findings clarify how PLK1-mediated phosphorylation prevents premature checkpoint inactivation, with important implications for cell cycle research and targeted cancer therapeutics.

15580 records 1/1039 page Next 12345 下5页 Last page